tradingkey.logo

Korro Bio Inc <KRRO.OQ> expected to post a loss of $2.56 a share - Earnings Preview

ReutersAug 8, 2025 9:44 PM
  • Korro Bio Inc KRRO.OQ KRRO.O is expected to show a rise in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2025

  • The Cambridge Massachusetts-based company is expected to report revenue of $508.63 thousand, according to the mean estimate from 8 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Korro Bio Inc is for a loss of $2.56 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Korro Bio Inc is $90.00, about 82.4% above its last closing price of $15.86

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-2.55

-2.60

-2.49

Beat

4.4

Dec. 31 2025

-2.00

-2.48

-2.26

Beat

8.9

Sep. 30 2024

-2.60

-2.61

-2.26

Beat

13.4​

Jun. 30 2024

-2.40

-2.39

-2.43

Missed

-1.5

​​Mar. 31 2024

-2.49

-2.51

-2.44

Beat

2.8

Dec. 31 2023

-2.57

-2.36

-25.65

Missed

-985.3​

Sep. 30 2023

-16.50

-17.72

-15.50

Beat

12.6

Jun. 30 2023

-17.34

-17.76

-15.00

Beat

15.6

This summary was machine generated August 8 at 21:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI